Risks and benefits of the treatment of psoriasis.
D000284:Administration, Oral; D000818:Animals; D002280:Basal Cell Carcinoma / Q000209:etiology; D002294:Carcinoma, Squamous Cell / Q000209:etiology; D003033:Coal Tar / Q000627:therapeutic use; D011564:Furocoumarins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008730:Methoxsalen / Q000008:administration & dosage / Q000627:therapeutic use; D010778:Photochemotherapy / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy / Q000628:therapy*; D011839:Radiation, Ionizing / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D012306:Risk; D012878:Skin Neoplasms / Q000209:etiology; D014467:Ultraviolet Therapy / Q000009:adverse effects
D011564:Furocoumarins; D003033:Coal Tar; D008730:Methoxsalen